Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Study of Intrabucally Administered Electromagnetic Fields Versus Placebo for Patients With Child-Pugh A or B With Advanced Hepatocellular Carcinoma

NCT04797884 is registered in ClinicalTrials.gov with THERABIONIC INC. as lead sponsor.

NCT NCT04797884
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04797884 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Study of Intrabucally Administered Electromagnetic Fields Versus Placebo for Patients With Child-Pugh A or B With Advanced Hepatocellular Carcinoma
Lead sponsor
THERABIONIC INC.
Phase
Phase 2/3
Overall status
Unknown status
Start date
July 31, 2023
Completion date
October 30, 2024
Enrollment
166 (estimated)
Sites
7

Conditions

As the registry lists them; a condition with its own page is linked.

hepatocellular carcinoma